MTOR and leukemia: By inhibiting c-Myc expression, MAC has apoptotic effects of K562 leukemia cells without affecting normal blood cells by the stimulation of AMP-activated protein kinase (AMPK) and inhibition of mammalian target of rapamycin (mTOR) phosphorylation [20].